275 related articles for article (PubMed ID: 26126522)
1. YAP is closely correlated with castration-resistant prostate cancer, and downregulation of YAP reduces proliferation and induces apoptosis of PC-3 cells.
Sheng X; Li WB; Wang DL; Chen KH; Cao JJ; Luo Z; He J; Li MC; Liu WJ; Yu C
Mol Med Rep; 2015 Oct; 12(4):4867-76. PubMed ID: 26126522
[TBL] [Abstract][Full Text] [Related]
2. YAP knockdown inhibits proliferation and induces apoptosis of human prostate cancer DU145 cells.
Jin X; Zhao W; Zhou P; Niu T
Mol Med Rep; 2018 Mar; 17(3):3783-3788. PubMed ID: 29286134
[TBL] [Abstract][Full Text] [Related]
3. The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.
Zhang L; Yang S; Chen X; Stauffer S; Yu F; Lele SM; Fu K; Datta K; Palermo N; Chen Y; Dong J
Mol Cell Biol; 2015 Apr; 35(8):1350-62. PubMed ID: 25645929
[TBL] [Abstract][Full Text] [Related]
4. miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance.
Guo Y; Cui J; Ji Z; Cheng C; Zhang K; Zhang C; Chu M; Zhao Q; Yu Z; Zhang Y; Fang YX; Gao WQ; Zhu HH
Oncogene; 2017 Nov; 36(45):6336-6347. PubMed ID: 28745315
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of Yes-Associated Protein Induces the Apoptosis While Inhibits the Proliferation of Human Periodontal Ligament Stem Cells through Crosstalk between Erk and Bcl-2 Signaling Pathways.
Wen Y; Ji Y; Zhang Y; Jiang B; Tang C; Wang Q; Chen X; Jia L; Gu W; Xu X
Int J Med Sci; 2017; 14(12):1231-1240. PubMed ID: 29104479
[No Abstract] [Full Text] [Related]
6. Loss of YAP protein in prostate cancer is associated with Gleason score increase.
Hu X; Jia Y; Yu J; Chen J; Fu Q
Tumori; 2015; 101(2):189-93. PubMed ID: 25908048
[TBL] [Abstract][Full Text] [Related]
7. YAP is overexpressed in clear cell renal cell carcinoma and its knockdown reduces cell proliferation and induces cell cycle arrest and apoptosis.
Cao JJ; Zhao XM; Wang DL; Chen KH; Sheng X; Li WB; Li MC; Liu WJ; He J
Oncol Rep; 2014 Oct; 32(4):1594-600. PubMed ID: 25175178
[TBL] [Abstract][Full Text] [Related]
8. Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3.
Ma B; Zhang H; Wang Y; Zhao A; Zhu Z; Bao X; Sun Y; Li L; Zhang Q
J Exp Clin Cancer Res; 2018 Sep; 37(1):210. PubMed ID: 30176898
[TBL] [Abstract][Full Text] [Related]
9. MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer.
Li Q; Wang M; Hu Y; Zhao E; Li J; Ren L; Wang M; Xu Y; Liang Q; Zhang D; Lai Y; Liu S; Peng X; Zhu C; Ye L
Theranostics; 2021; 11(12):5794-5812. PubMed ID: 33897882
[No Abstract] [Full Text] [Related]
10. Expression of Yes-associated protein in gastric adenocarcinoma and inhibitory effects of its knockdown on gastric cancer cell proliferation and metastasis.
Zhang J; Xu ZP; Yang YC; Zhu JS; Zhou Z; Chen WX
Int J Immunopathol Pharmacol; 2012; 25(3):583-90. PubMed ID: 23058008
[TBL] [Abstract][Full Text] [Related]
11. Effects of INPP4B gene transfection combined with PARP inhibitor on castration therapy-resistant prostate cancer cell line, PC3.
Ding H; Sun Y; Hou Y; Li L
Urol Oncol; 2014 Jul; 32(5):720-6. PubMed ID: 24837011
[TBL] [Abstract][Full Text] [Related]
12. Identification of PRL1 as a novel diagnostic and therapeutic target for castration-resistant prostate cancer by the Escherichia coli ampicillin secretion trap (CAST) method.
Shinmei S; Sentani K; Hayashi T; Sakamoto N; Goto K; Oo HZ; Naito Y; Teishima J; Matsubara A; Oue N; Kuniyasu H; Yasui W
Urol Oncol; 2014 Aug; 32(6):769-78. PubMed ID: 24968948
[TBL] [Abstract][Full Text] [Related]
13. Aspalathin-rich green Aspalathus linearis extract suppresses migration and invasion of human castration-resistant prostate cancer cells via inhibition of YAP signaling.
Huang SH; Kao YH; Muller CJF; Joubert E; Chuu CP
Phytomedicine; 2020 Apr; 69():153210. PubMed ID: 32217447
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer.
Rönnau CGH; Fussek S; Smit FP; Aalders TW; van Hooij O; Pinto PMC; Burchardt M; Schalken JA; Verhaegh GW
World J Urol; 2021 Oct; 39(10):3789-3797. PubMed ID: 33990872
[TBL] [Abstract][Full Text] [Related]
15. lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5.
Gu P; Chen X; Xie R; Han J; Xie W; Wang B; Dong W; Chen C; Yang M; Jiang J; Chen Z; Huang J; Lin T
Mol Ther; 2017 Aug; 25(8):1959-1973. PubMed ID: 28487115
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic receptors promote castration-resistant growth of prostate cancer through a FAK-YAP signaling axis.
Goto Y; Ando T; Izumi H; Feng X; Arang N; Gilardi M; Wang Z; Ando K; Gutkind JS
Oncogene; 2020 May; 39(20):4014-4027. PubMed ID: 32205868
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
18. IMPORTANCE OF APOPTOSIS MARKERS (MDM2, BCL-2 AND Bax) IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER.
Saker Z; Tsintsadze O; Jiqia I; Managadze L; Chkhotua A
Georgian Med News; 2015 Dec; (249):7-14. PubMed ID: 26719543
[TBL] [Abstract][Full Text] [Related]
19. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y
Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736
[TBL] [Abstract][Full Text] [Related]
20. Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity.
Ding G; Wang J; Feng C; Jiang H; Xu J; Ding Q
Oncotarget; 2016 Sep; 7(39):64309-64317. PubMed ID: 27602760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]